$BDPT
BIOADAPTIVES, INC.

2021 Q3 Form 10-Q Financial Statement

#000164033421001817 Filed on August 12, 2021

View on sec.gov

Income Statement

Concept 2021 Q3 2021 Q2 2020 Q2
Revenue $5.342K $6.065K $3.502K
YoY Change 20.34% 73.19% -32.26%
Cost Of Revenue $2.227K $2.713K $3.355K
YoY Change -34.27% -19.14% 126.69%
Gross Profit $3.115K $3.352K $147.00
YoY Change 196.38% 2180.27% -96.02%
Gross Profit Margin 58.31% 55.27% 4.2%
Selling, General & Admin $131.4K $49.33K $73.38K
YoY Change 411.05% -32.77% 74.92%
% of Gross Profit 4217.98% 1471.66% 49918.37%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $44.58K $25.62K
YoY Change
% of Gross Profit 1431.14% 764.32%
Operating Expenses $176.0K $74.95K $73.38K
YoY Change 584.41% 2.15% 74.92%
Operating Profit -$172.9K -$71.60K -$73.23K
YoY Change 600.94% -2.23% 91.41%
Interest Expense $64.54K $15.83K $58.92K
YoY Change -2.52% -73.13% -141.61%
% of Operating Profit
Other Income/Expense, Net $138.3K -$237.6K -$357.2K
YoY Change 1135.48% -33.47%
Pretax Income -$34.52K -$309.2K -$430.4K
YoY Change 156.38% -28.16% 139.3%
Income Tax
% Of Pretax Income
Net Earnings -$34.52K -$309.2K -$430.4K
YoY Change 156.38% -28.16% 139.3%
Net Earnings / Revenue -646.13% -5098.86% -12291.12%
Basic Earnings Per Share
Diluted Earnings Per Share -$1.021K -$9.362K -$21.71K
COMMON SHARES
Basic Shares Outstanding 33.02M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2021 Q3 2021 Q2 2020 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $66.68K $70.27K $4.060K
YoY Change 349.33% 1630.79% -70.08%
Cash & Equivalents $66.34K $69.51K
Short-Term Investments $340.00 $760.00 $60.00
Other Short-Term Assets $1.000K $0.00
YoY Change
Inventory $9.601K $10.70K $18.24K
Prepaid Expenses $1.000K $0.00
Receivables
Other Receivables
Total Short-Term Assets $77.28K $80.97K $22.31K
YoY Change 141.42% 262.94% 4.79%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $101.4K $55.00K $0.00
YoY Change
TOTAL ASSETS
Total Short-Term Assets $77.28K $80.97K $22.31K
Total Long-Term Assets $101.4K $55.00K $0.00
Total Assets $178.7K $136.0K $22.31K
YoY Change 458.25% 509.46% 4.79%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $190.5K $83.58K $71.44K
YoY Change 171.2% 16.99% 111.17%
Accrued Expenses $55.31K $4.493K
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $479.9K $523.0K $425.1K
YoY Change 3.42% 23.02% 161.73%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $1.391M $1.488M $1.347M
YoY Change 8.24% 10.5% 81.44%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change -100.0%
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00 $0.00 $0.00
YoY Change -100.0%
TOTAL LIABILITIES
Total Short-Term Liabilities $1.391M $1.488M $1.347M
Total Long-Term Liabilities $0.00 $0.00 $0.00
Total Liabilities $1.391M $1.488M $1.347M
YoY Change 8.24% 10.5% 77.07%
SHAREHOLDERS EQUITY
Retained Earnings -$6.442M
YoY Change
Common Stock $3.580K $3.303K
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$1.212M -$1.352M -$1.324M
YoY Change
Total Liabilities & Shareholders Equity $178.7K $136.0K $22.31K
YoY Change 458.25% 509.46% 4.79%

Cashflow Statement

Concept 2021 Q3 2021 Q2 2020 Q2
OPERATING ACTIVITIES
Net Income -$34.52K -$309.2K -$430.4K
YoY Change 156.38% -28.16% 139.3%
Depreciation, Depletion And Amortization $44.58K $25.62K
YoY Change
Cash From Operating Activities -$33.18K -$29.71K -$20.24K
YoY Change -3.77% 46.79% 62.57%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 30.00K 75.00K 12.58K
YoY Change -33.23% 496.18% 151.6%
NET CHANGE
Cash From Operating Activities -33.18K -29.71K -20.24K
Cash From Investing Activities
Cash From Financing Activities 30.00K 75.00K 12.58K
Net Change In Cash -3.180K 45.29K -7.660K
YoY Change -130.43% -691.25% 2.82%
FREE CASH FLOW
Cash From Operating Activities -$33.18K -$29.71K -$20.24K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2021Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
33022425 shares
CY2021Q2 us-gaap Cash
Cash
69513 USD
CY2020Q4 us-gaap Cash
Cash
4587 USD
CY2021Q2 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
0 USD
CY2020Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
0 USD
CY2021Q2 us-gaap Inventory Net
InventoryNet
10697 USD
CY2020Q4 us-gaap Inventory Net
InventoryNet
13815 USD
CY2021Q2 us-gaap Assets Current
AssetsCurrent
80971 USD
CY2020Q4 us-gaap Assets Current
AssetsCurrent
18846 USD
CY2021Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
55000 USD
CY2020Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
0 USD
CY2021Q2 us-gaap Assets
Assets
135971 USD
CY2020Q4 us-gaap Assets
Assets
18846 USD
CY2021Q2 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
83583 USD
CY2020Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
87561 USD
CY2021Q2 us-gaap Derivative Liabilities
DerivativeLiabilities
881311 USD
CY2020Q4 us-gaap Derivative Liabilities
DerivativeLiabilities
827119 USD
CY2021Q2 bdpt Convertible Notes Net Of Discount
ConvertibleNotesNetOfDiscount
6396 USD
CY2020Q4 bdpt Convertible Notes Net Of Discount
ConvertibleNotesNetOfDiscount
4764 USD
CY2021Q2 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
479284 USD
CY2020Q4 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
405236 USD
CY2021Q2 us-gaap Notes Payable Related Parties Classified Current
NotesPayableRelatedPartiesClassifiedCurrent
43715 USD
CY2020Q4 us-gaap Notes Payable Related Parties Classified Current
NotesPayableRelatedPartiesClassifiedCurrent
77715 USD
CY2021Q2 us-gaap Liabilities Current
LiabilitiesCurrent
1487893 USD
CY2020Q4 us-gaap Liabilities Current
LiabilitiesCurrent
1397631 USD
CY2021Q2 us-gaap Liabilities
Liabilities
1487893 USD
CY2020Q4 us-gaap Liabilities
Liabilities
1397631 USD
CY2021Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2021Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2021Q2 us-gaap Preferred Stock Value
PreferredStockValue
110 USD
CY2020Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2021Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2021Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000 shares
CY2021Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
33032425 shares
CY2020Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
21591942 shares
CY2021Q2 us-gaap Common Stock Capital Shares Reserved For Future Issuance
CommonStockCapitalSharesReservedForFutureIssuance
10000 shares
CY2020Q4 us-gaap Common Stock Capital Shares Reserved For Future Issuance
CommonStockCapitalSharesReservedForFutureIssuance
762390 shares
CY2021Q2 us-gaap Common Stock Value
CommonStockValue
3303 USD
CY2020Q4 us-gaap Common Stock Value
CommonStockValue
2159 USD
CY2021Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
5051975 USD
CY2020Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
4225217 USD
CY2020Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-5606161 USD
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
-1351922 USD
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
-1378785 USD
CY2021Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
135971 USD
CY2020Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
18846 USD
CY2021Q2 us-gaap Revenues
Revenues
6065 USD
CY2020Q2 us-gaap Revenues
Revenues
3502 USD
us-gaap Revenues
Revenues
10583 USD
us-gaap Revenues
Revenues
8157 USD
CY2021Q2 us-gaap Cost Of Revenue
CostOfRevenue
2713 USD
CY2020Q2 us-gaap Cost Of Revenue
CostOfRevenue
3355 USD
us-gaap Cost Of Revenue
CostOfRevenue
4735 USD
us-gaap Cost Of Revenue
CostOfRevenue
4717 USD
CY2021Q2 us-gaap Gross Profit
GrossProfit
3352 USD
CY2020Q2 us-gaap Gross Profit
GrossProfit
147 USD
us-gaap Gross Profit
GrossProfit
5848 USD
us-gaap Gross Profit
GrossProfit
3440 USD
CY2021Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
33690 USD
CY2020Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
8494 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
42320 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
47926 USD
CY2021Q2 us-gaap Professional Fees
ProfessionalFees
15639 USD
CY2020Q2 us-gaap Professional Fees
ProfessionalFees
18621 USD
us-gaap Professional Fees
ProfessionalFees
37622 USD
us-gaap Professional Fees
ProfessionalFees
27711 USD
CY2020Q2 bdpt Stock Based Compensation
StockBasedCompensation
46264 USD
bdpt Stock Based Compensation
StockBasedCompensation
163900 USD
bdpt Stock Based Compensation
StockBasedCompensation
139643 USD
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
-491903 USD
CY2021Q2 bdpt Amortization Of License
AmortizationOfLicense
25625 USD
CY2021Q2 bdpt Stock Based Compensation
StockBasedCompensation
0 USD
bdpt Amortization Of License
AmortizationOfLicense
47500 USD
CY2020Q2 bdpt Amortization Of License
AmortizationOfLicense
0 USD
CY2021Q2 us-gaap Operating Expenses
OperatingExpenses
74954 USD
CY2020Q2 us-gaap Operating Expenses
OperatingExpenses
73379 USD
us-gaap Operating Expenses
OperatingExpenses
291342 USD
us-gaap Operating Expenses
OperatingExpenses
215280 USD
CY2021Q2 us-gaap Marketable Securities Unrealized Gain Loss
MarketableSecuritiesUnrealizedGainLoss
-2517 USD
CY2020Q2 us-gaap Marketable Securities Unrealized Gain Loss
MarketableSecuritiesUnrealizedGainLoss
-349 USD
us-gaap Marketable Securities Unrealized Gain Loss
MarketableSecuritiesUnrealizedGainLoss
317 USD
us-gaap Marketable Securities Unrealized Gain Loss
MarketableSecuritiesUnrealizedGainLoss
-709 USD
CY2021Q2 us-gaap Interest Expense
InterestExpense
15833 USD
CY2020Q2 us-gaap Interest Expense
InterestExpense
58921 USD
us-gaap Interest Expense
InterestExpense
77249 USD
us-gaap Interest Expense
InterestExpense
112504 USD
CY2021Q2 us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
-219294 USD
CY2020Q2 us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
-297933 USD
us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
-387723 USD
us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
-343304 USD
bdpt Amortization Of License
AmortizationOfLicense
0 USD
CY2021Q2 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0 USD
CY2021Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-237644 USD
CY2020Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-357203 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-456517 USD
CY2021Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-309246 USD
CY2020Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-430435 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-801149 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-668357 USD
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
-309246 USD
CY2020Q2 us-gaap Net Income Loss
NetIncomeLoss
-430435 USD
us-gaap Net Income Loss
NetIncomeLoss
-801149 USD
us-gaap Net Income Loss
NetIncomeLoss
-668357 USD
CY2021Q2 bdpt Basic And Diluted Shares
BasicAndDilutedShares
-0.01
CY2020Q2 bdpt Basic And Diluted Shares
BasicAndDilutedShares
-0.02
bdpt Basic And Diluted Shares
BasicAndDilutedShares
-0.03
bdpt Basic And Diluted Shares
BasicAndDilutedShares
-0.03
CY2021Q2 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
33032425 shares
CY2020Q2 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
19822574 shares
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
30603899 shares
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
19545347 shares
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
-1378785 USD
CY2021Q1 bdpt Series A Preferred Stock Issued For Settlement Of Debt Related Party Amount
SeriesAPreferredStockIssuedForSettlementOfDebtRelatedPartyAmount
75000 USD
CY2021Q1 bdpt Series A Preferred Stock Issued For License Fee Amount
SeriesAPreferredStockIssuedForLicenseFeeAmount
102500 USD
CY2021Q1 bdpt Common Stock Issued For Conversion Of Debt Amount
CommonStockIssuedForConversionOfDebtAmount
486612 USD
CY2021Q1 bdpt Common Stock Issued For Service Amount
CommonStockIssuedForServiceAmount
163900 USD
CY2021Q1 bdpt Cancellation Of Common Stock Officers Amount
CancellationOfCommonStockOfficersAmount
0 USD
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
-1042676 USD
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
-309246 USD
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
-1351922 USD
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
-839876 USD
CY2020Q1 bdpt Common Stock Issued For Service Amount
CommonStockIssuedForServiceAmount
47115 USD
CY2020Q1 bdpt Common Stock Issued For Service Related Party Amount
CommonStockIssuedForServiceRelatedPartyAmount
36000 USD
CY2020Q1 bdpt Stock Based Compensation
StockBasedCompensation
10264 USD
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
-237922 USD
CY2020Q1 us-gaap Stockholders Equity
StockholdersEquity
-984419 USD
CY2020Q2 bdpt Common Stock Issued For Conversion Of Debt Amount
CommonStockIssuedForConversionOfDebtAmount
44380 USD
CY2020Q2 bdpt Common Stock Issued For Service Related Party Amount
CommonStockIssuedForServiceRelatedPartyAmount
36000 USD
CY2020Q2 us-gaap Net Income Loss
NetIncomeLoss
-430435 USD
CY2020Q2 us-gaap Stockholders Equity
StockholdersEquity
-1324210 USD
us-gaap Net Income Loss
NetIncomeLoss
-801149 USD
us-gaap Net Income Loss
NetIncomeLoss
-668357 USD
us-gaap Share Based Compensation
ShareBasedCompensation
163900 USD
us-gaap Share Based Compensation
ShareBasedCompensation
47115 USD
bdpt Stock Based Compensation Related Party
StockBasedCompensationRelatedParty
0 USD
bdpt Stock Based Compensation Related Party
StockBasedCompensationRelatedParty
92528 USD
us-gaap Increase Decrease In Derivative Assets And Liabilities
IncreaseDecreaseInDerivativeAssetsAndLiabilities
387723 USD
us-gaap Increase Decrease In Derivative Assets And Liabilities
IncreaseDecreaseInDerivativeAssetsAndLiabilities
410304 USD
bdpt Amortization Of License
AmortizationOfLicense
47500 USD
bdpt Amortization Of License
AmortizationOfLicense
0 USD
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
48048 USD
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
19577 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
3118 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-7116 USD
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
10103 USD
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
42694 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-90074 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-62546 USD
us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
0 USD
us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
9800 USD
us-gaap Proceeds From Repayments Of Notes Payable
ProceedsFromRepaymentsOfNotesPayable
0 USD
us-gaap Proceeds From Repayments Of Notes Payable
ProceedsFromRepaymentsOfNotesPayable
-14840 USD
us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
1623 USD
us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
0 USD
us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
1623 USD
us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
0 USD
us-gaap Proceeds From Repayments Of Related Party Debt
ProceedsFromRepaymentsOfRelatedPartyDebt
0 USD
us-gaap Proceeds From Repayments Of Related Party Debt
ProceedsFromRepaymentsOfRelatedPartyDebt
19272 USD
us-gaap Repayments Of Other Debt
RepaymentsOfOtherDebt
10000 USD
us-gaap Repayments Of Other Debt
RepaymentsOfOtherDebt
0 USD
us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
165000 USD
us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
40000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
155000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
54232 USD
us-gaap Cash Period Increase Decrease
CashPeriodIncreaseDecrease
64926 USD
us-gaap Cash Period Increase Decrease
CashPeriodIncreaseDecrease
-8314 USD
CY2020Q4 us-gaap Cash
Cash
4587 USD
CY2019Q4 us-gaap Cash
Cash
12313 USD
CY2021Q2 us-gaap Cash
Cash
69513 USD
CY2020Q2 us-gaap Cash
Cash
3999 USD
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0 USD
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0 USD
us-gaap Interest Paid Net
InterestPaidNet
16424 USD
us-gaap Interest Paid Net
InterestPaidNet
0 USD
bdpt Derivative Liability Recognized As Debt Discount
DerivativeLiabilityRecognizedAsDebtDiscount
40000 USD
bdpt Derivative Liability Recognized As Debt Discount
DerivativeLiabilityRecognizedAsDebtDiscount
0 USD
bdpt Issuance Of Common Stock For Conversion Of Debt
IssuanceOfCommonStockForConversionOfDebt
486612 USD
bdpt Issuance Of Common Stock For Conversion Of Debt
IssuanceOfCommonStockForConversionOfDebt
44380 USD
bdpt Issuance Series A Preferred Stock For License Fee
IssuanceSeriesAPreferredStockForLicenseFee
102500 USD
bdpt Issuance Series A Preferred Stock For License Fee
IssuanceSeriesAPreferredStockForLicenseFee
0 USD
bdpt Issuance Series A Preferred Stock For Settlement Of Debt Related Party
IssuanceSeriesAPreferredStockForSettlementOfDebtRelatedParty
60 USD
bdpt Issuance Series A Preferred Stock For Settlement Of Debt Related Party
IssuanceSeriesAPreferredStockForSettlementOfDebtRelatedParty
0 USD
bdpt Cancellation Of Common Stock
CancellationOfCommonStock
35 USD
bdpt Cancellation Of Common Stock
CancellationOfCommonStock
0 USD
us-gaap Use Of Estimates
UseOfEstimates
<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The preparation of consolidated financial statements in conformity with US GAAP requires the Company to make estimates and judgments that affect the reported amounts of assets and liabilities, revenues and expenses, and related disclosures of contingent assets and liabilities. These estimates and judgments are based on historical information, information that is currently available to the Company, and on various other assumptions that the Company believes to be reasonable under the circumstances. Actual results could differ from those estimates.</p>
CY2020Q2 us-gaap Derivative Fair Value Of Derivative Net
DerivativeFairValueOfDerivativeNet
141805 USD
bdpt Loss On Derivative Instruments Related To Convertible Notes
LossOnDerivativeInstrumentsRelatedToConvertibleNotes
101805 USD
CY2021Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
4493 USD
CY2020Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
3438 USD

Files In Submission

Name View Source Status
0001640334-21-001817-index-headers.html Edgar Link pending
0001640334-21-001817-index.html Edgar Link pending
0001640334-21-001817.txt Edgar Link pending
0001640334-21-001817-xbrl.zip Edgar Link pending
bdpt-20210630.xsd Edgar Link pending
bdpt-20210630_cal.xml Edgar Link unprocessable
bdpt-20210630_def.xml Edgar Link unprocessable
bdpt-20210630_lab.xml Edgar Link unprocessable
bdpt-20210630_pre.xml Edgar Link unprocessable
bdpt_10q.htm Edgar Link pending
bdpt_10qimg1.jpg Edgar Link pending
bdpt_10q_htm.xml Edgar Link completed
bdpt_ex311.htm Edgar Link pending
bdpt_ex312.htm Edgar Link pending
bdpt_ex321.htm Edgar Link pending
bdpt_ex322.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending